Home
Scholarly Works
Dosing decisions in severe hemophilia a: can we...
Conference

Dosing decisions in severe hemophilia a: can we aim lower? FVIII use in a cohort of Canadian patients in 2009

Authors

Bos C; Chan A; Webert K; Walker I; Almonte T; Decker K; Goldsmith R; Strike K; Waterhouse L

Volume

9

Pagination

pp. 681-681

Publisher

WILEY-BLACKWELL

Publication Date

July 1, 2011

Conference proceedings

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

ISSN

1538-7933

Contact the Experts team